Richard Chesworth, Chief Scientific Officer at Kymera Therapeutics, Inc. (KYMR), sold 107,712 shares at $51.68 ($5.4M) on 2021-08-17, disclosed to the SEC on 2021-08-19.
Open-market sale of $5.4M KYMR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.90 | 8,809 | $440K | 8.1% |
| 2 | $49.90 | 8,809 | $440K | 8.1% |
| 3 | $50.37 | 41,975 | $2.1M | 39.0% |
| 4 | $50.37 | 41,975 | $2.1M | 39.0% |
| 5 | $51.68 | 2,928 | $151K | 2.8% |
| 6 | $51.68 | 2,928 |
| $151K |
| 2.8% |
| 7 | $52.09 | 288 | $15K | 0.3% |
| Total | $50.37 avg | 107,712 | $5.4M | 100% |